Publication Information (EuropePMC) | |
Title | Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications. |
PubMed ID | 40133288(Europe PMC) |
doi | 10.1038/s41467-025-58152-3 |
Publication Date | March 25, 2025 |
Journal | Nat Commun |
Author(s) | Sadler MC, Apostolov A, Cevallos C, Auwerx C, Ribeiro DM, Altman RB, Kutalik Z. |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS002150 (portability-ldpred2_LDL) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
LDL direct | low density lipoprotein cholesterol measurement | 360,007 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002150/ScoringFiles/PGS002150.txt.gz |
PGS002108 (portability-ldpred2_cholesterol) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Cholesterol | total cholesterol measurement | 451,160 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002108/ScoringFiles/PGS002108.txt.gz |
PGS002193 (portability-ldpred2_log_pulse_rate) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Pulse rate, automated reading | heart rate | 858,487 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002193/ScoringFiles/PGS002193.txt.gz |
PGS002228 (portability-ldpred2_systolic_BP) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Systolic blood pressure, automated reading | systolic blood pressure | 937,030 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002228/ScoringFiles/PGS002228.txt.gz |
PGS002171 (portability-ldpred2_log_HbA1c) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
Glycated haemoglobin (HbA1c) | HbA1c measurement | 736,730 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002171/ScoringFiles/PGS002171.txt.gz |
PGS002172 (portability-ldpred2_log_HDL) |
PGP000263 | Privé F et al. Am J Hum Genet (2022) |
HDL cholesterol | high density lipoprotein cholesterol measurement | 732,902 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002172/ScoringFiles/PGS002172.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM022508 | PGS002150 (portability-ldpred2_LDL) |
PSS011978| European Ancestry| 18,753 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: LDL-C response to statin (absolute difference) | β: -0.092 (0.006) | — | — | sex, age and drug-specific covariates | beta unit = mmol/L |
PPM022509 | PGS002150 (portability-ldpred2_LDL) |
PSS011978| European Ancestry| 18,753 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: LDL-C response to statin (relative logarithmic difference) | β: 2.469 (0.202) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022510 | PGS002108 (portability-ldpred2_cholesterol) |
PSS011984| European Ancestry| 28,880 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: Total cholesterol response to statin (absolute difference) | β: -0.057 (0.005) | — | — | sex, age and drug-specific covariates | beta unit = mmol/L |
PPM022511 | PGS002108 (portability-ldpred2_cholesterol) |
PSS011984| European Ancestry| 28,880 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: Total cholesterol response to statin (relative logarithmic difference) | β: 0.858 (0.095) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022512 | PGS002172 (portability-ldpred2_log_HDL) |
PSS011975| European Ancestry| 25,405 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: HDL-C response to statin (absolute difference) | β: 0.002 (0.001) | — | — | sex, age and drug-specific covariates | beta unit = mmol/L |
PPM022513 | PGS002172 (portability-ldpred2_log_HDL) |
PSS011975| European Ancestry| 25,405 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: HDL-C response to statin (relative logarithmic difference) | β: 0.116 (0.088) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022514 | PGS002171 (portability-ldpred2_log_HbA1c) |
PSS011977| European Ancestry| 4,424 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: HbA1c response to metformin (absolute difference) | β: 0.382 (0.246) | — | — | sex, age and drug-specific covariates | beta unit = mmol/mol |
PPM022515 | PGS002171 (portability-ldpred2_log_HbA1c) |
PSS011977| European Ancestry| 4,424 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: HbA1c response to metformin (relative logarithmic difference) | β: 1.003 (0.352) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022516 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011983| European Ancestry| 8,250 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to antihypertensives (absolute difference) | β: -0.456 (0.18) | — | — | sex, age and drug-specific covariates | beta unit = mmHg |
PPM022517 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011983| European Ancestry| 8,250 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to antihypertensives (relative logarithmic difference) | β: -0.153 (0.121) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022518 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011979| European Ancestry| 5,034 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to ACEi (absolute difference) | β: -0.557 (0.227) | — | — | sex, age and drug-specific covariates | beta unit = mmHg |
PPM022519 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011979| European Ancestry| 5,034 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to ACEi (relative logarithmic difference) | β: -0.208 (0.153) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022520 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011981| European Ancestry| 932 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to CCB (absolute difference) | β: -0.826 (0.595) | — | — | sex, age and drug-specific covariates | beta unit = mmHg |
PPM022521 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011981| European Ancestry| 932 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to CCB (relative logarithmic difference) | β: -0.331 (0.392) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022522 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011982| European Ancestry| 2,145 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to diuretics (absolute difference) | β: -0.289 (0.343) | — | — | sex, age and drug-specific covariates | beta unit = mmHg |
PPM022523 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011982| European Ancestry| 2,145 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to diuretics (relative logarithmic difference) | β: -0.102 (0.228) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022524 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011980| European Ancestry| 1,750 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to beta blockers (absolute difference) | β: -0.094 (0.415) | — | — | sex, age and drug-specific covariates | beta unit = mmHg |
PPM022525 | PGS002228 (portability-ldpred2_systolic_BP) |
PSS011980| European Ancestry| 1,750 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: SBP response to beta blockers (relative logarithmic difference) | β: 0.068 (0.284) | — | — | sex, age and drug-specific covariates | beta unit = % |
PPM022526 | PGS002193 (portability-ldpred2_log_pulse_rate) |
PSS011976| European Ancestry| 2,157 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: Heart rate response to beta blockers (absolute difference) | β: -0.002 (0.299) | — | — | sex, age and drug-specific covariates | beta unit = beats/min |
PPM022527 | PGS002193 (portability-ldpred2_log_pulse_rate) |
PSS011976| European Ancestry| 2,157 individuals |
PGP000721 | Sadler MC et al. Nat Commun (2025) |Ext. |
Reported Trait: Heart rate response to beta blockers (relative logarithmic difference) | β: 0.475 (0.38) | — | — | sex, age and drug-specific covariates | beta unit = % |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011975 | — | — | 25,405 individuals | — | European (British) |
— | UKB | — |
PSS011976 | — | — | 2,157 individuals | — | European (British) |
— | UKB | — |
PSS011977 | — | — | 4,424 individuals | — | European (British) |
— | UKB | — |
PSS011978 | — | — | 18,753 individuals | — | European (British) |
— | UKB | — |
PSS011979 | — | — | 5,034 individuals | — | European (British) |
— | UKB | — |
PSS011980 | — | — | 1,750 individuals | — | European (British) |
— | UKB | — |
PSS011981 | — | — | 932 individuals | — | European (British) |
— | UKB | — |
PSS011982 | — | — | 2,145 individuals | — | European (British) |
— | UKB | — |
PSS011983 | — | — | 8,250 individuals | — | European (British) |
— | UKB | — |
PSS011984 | — | — | 28,880 individuals | — | European (British) |
— | UKB | — |